Health Condition 1: K30- Functional dyspepsia
Conditions
Interventions
Intervention1: Lavan Bhaskar Churna orally along with Ayurveda Lifestyle Advocacy
: •Dose: 3 gram, twice daily
•Route of administration: Oral
•Time of administration: Just five minutes after finishing
Sponsors
Central Council for Research in Ayurvedic Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient diagnosed with Amajirna (as per Ayurvedic classics) having the following symptoms/signs I.? ?? ???(Heaviness of whole body/ abdomen), II.?? ????? ?????? ?? ??????? ???(belching /eructations just after meal), III.?? ?? ????(Nausea), IV.?? ?????(Swelling of the cheek), V.?? ?????????(Edema of the periorbital region), VI.? ???? ???? ????(sweet taste in mouth) 2.Willing and able to participate for 4 weeks & Subject should be able to provide a written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients suffering with other type of Ajirna viz. Vishatbdhajirna, Vidagdhajirna, Rasasheshajirna, Dinapakiajirna, Prakrutajirna 2.Subject with Red alarm features (unintentional weight loss, persistent vomiting, dysphagia, hematemesis, melena, fever, or jaundice) 3.Subject with known history of serious gastrointestinal disease (including peptic ulcers, malignancy, esophagealdysmotility, a previous endoscopic or radiological diagnosis of GERD and Barrett’s esophagus) 4.Patients with (Known cases of) Hypertension ( > 130/80mmHg). 5.Concomitant serious disease of vital organs such as the liver, kidney, heart or lungs. 6.Women who are pregnant, lactating, or planning to conceive. 7.Patients on prolonged (=6 weeks) medication with corticosteroids, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study. 8.History of hypersensitivity to any of the trial drugs or their ingredients. 9.Patients who are judged by the investigators to be unsuitable to participate in the clinical trial (diagnosed psychotic illnesses, substance dependence or alcoholism) 10.Any other condition which the Investigator thinks may jeopardize the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Changes in symptoms of Amajirna: [Time frame: baseline, 3rd Day, 7th days, 14th Day] ? ?? ???(Heaviness of whole body/ abdomen) ?? ????? ?????? ?? ??????? ???(belching /eructations just after meal) ?? ?? ????(Nausea) ?? ?????(Swelling of the cheek) ?? ?????????(Edema of the periorbital region) ? ???? ???? ????(sweet taste in mouth) Timepoint: 0,3rd,7th,14th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Psychological Assessment by Perceived Stress Scale(PSS) Timepoint: 0,3rd,7th,14th, 28th day;Agni assessment through Questionnaire prepared by CCRAS Timepoint: 0,3rd,7th,14th, 28th day;Disease relapse rate after treatment successTimepoint: after 2 weeks of post treatment period, based on reappearance of clinical symptoms(28th day) | — |
Countries
India
Contacts
Public ContactDr Shaizi Layeeq
Central Ayurveda Research Institute
Outcome results
None listed